论文部分内容阅读
目的观察血塞通注射液辅助治疗高脂血症性急性胰腺炎(HLAP)的临床效果。方法 60例HLAP患者随机分为两组,对照组给予常规治疗,治疗组在常规治疗基础上加用血塞通注射液,比较两组疗效并观察药物的毒副反应。结果治疗5天后治疗组血TG、CRP及APACHEⅡ评分较对照组均有明显降低,治疗组腹痛缓解时间、腹部压痛消失时间、平均住院天数明显短于对照组,两组均无药物的毒副反应发生。结论血塞通注射液辅助治疗HLAP安全有效。
Objective To observe the clinical effect of Xuesaitong injection in the treatment of hyperlipidemic acute pancreatitis (HLAP). Methods Sixty patients with HLAP were randomly divided into two groups. The control group was given conventional treatment. The treatment group was given Xuesaitong injection on the basis of routine treatment. The curative effect of the two groups were compared and the side effects of the drug were observed. Results The blood TG, CRP and APACHEⅡ scores in the treatment group were significantly lower than those in the control group after 5 days of treatment. The pain relief time, disappearance time of abdominal tenderness and average length of stay in the treatment group were significantly shorter than those in the control group. There was no drug side effects occur. Conclusion Xuesaitong injection adjuvant therapy HLAP safe and effective.